Tag: tDCS

HD-RECOVERY: Brain stimulation improves COVID-19 outcomes in randomised trial

In the randomised HD-RECOVERY clinical trial, the use of high-definition transcranial direct current stimulation (HD-tDCS) has been found to be associated with a statistically...

Self-administered tDCS reduces knee osteoarthritis pain in older adult patients

Home-based, self-administered transcranial direct current stimulation (tDCS) has demonstrated feasibility, acceptability and significant reductions in clinical pain intensity in older adults with knee osteoarthritis,...

Ybrain receives Translational Research Award for tDCS technology

Ybrain recently received the Translational Research Award at this year's Neuroergonomics and NYC Neuromodulation Conferences (28 July–1 August, New York City, USA) for its transcranial direct...

Randomised data support use of tDCS in Parkinson’s patients with Pisa...

Data from a randomised controlled trial (RCT), which have been published in Frontiers in Neurology, support the use of neuromodulation with transcranial direct current...

Neuromodulation offers hope for patients with long-COVID

With increasing focus being placed on the long-term impact COVID-19 can have, and the demand for effective treatments also growing concurrently, Marom Bikson (New...
tdcs autism

Multisession tDCS alongside cognitive remediation promotes social functioning in autism patients

In a randomised, sham-controlled clinical trial, multisession transcranial direct current stimulation (tDCS) paired with concurrent cognitive remediation training has been shown to promote social...

Neuromodulation for post-stroke recovery advancing on several fronts

As a principal investigator for the pivotal VNS-REHAB study, which supported the first US Food and Drug Administration (FDA) premarket approval of a vagus...

FDA approves launch of “largest clinical trial to date” for tDCS...

Flow Neuroscience, which claims to be the creator of Europe’s first medically approved brain stimulation device to treat depression at home, has received full...
flow neuroscience funding

Flow Neuroscience receives Series A funding to advance tDCS depression treatment

Flow Neuroscience, the creator of what is currently Europe’s only medically approved transcranial direct current stimulation (tDCS) device and behavioural therapy app for depression,...
tdcs mental health treatment

How stimulation is changing the future of mental health treatment

Daniel Månsson (Flow Neuroscience, Malmö, Sweden) outlines the benefits held by transcranial direct-current stimulation (tDCS) in the treatment of depression—and how clinical evidence supporting...
rtms therapy georgia stillianesis

rTMS found to be “well-accepted” for therapeutic use in psychiatric populations

Psychiatric populations perceive the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) for mental health conditions to be beneficial, safe, and no more dangerous...

Future stroke rehabilitation could include robotic therapy

At the North American Neuromodulation Society (NANS) virtual meeting (15–16 January), Dylan J Edwards, director of the Moss Rehabilitation Research Institute and director of...

Good news for gamblers: Transcranial direct current stimulation found to enhance...

Transcranial direct current stimulation (tDCS) offers a novel intervention for individuals with gambling disorder, concluded a recent study that found that its use enhanced...